Medical Science Liaison, Lung/GU Oncology (MA, NH, VT, ME)

Bristol Myers Squibb • Boston, MA

21h • $168,220 - $203,837 • Remote

About The Position

The primary role of the Medical Science Liaison (MSL) is to engage in meaningful peer-to-peer scientific dialogue with healthcare system leaders such as Regional Thought Leaders (RTLs), National Thought Leaders, and Healthcare Professional (HCPs) within a defined geography to translate science into patient care. MSLs will also engage the top HCPs in high-disease burden hospitals. The MSL captures medical insights and acts as a clinical & scientific advisor to cross-functional partners. Ensures applicable interactions are aligned with enterprise and medical strategies and ultimately serve to ensure patients have access to BMS medicines through their efforts to ensure the medical community is fully apprised of their safe and effective use. Additionally, the MSL will work with medical community to address other pertinent scientific related questions not limited to approved assets and indications. MSL engagement with HCPs is focused on pre- and peri-launch activities or according to lifecycle needs of the brand. The MSL will also engage in educational dialogue with relevant HCPs and share relevant clinical evidence and information based on the physicians’ needs and in accordance with the field medical plan. This role is field-based, and it is anticipated that the employee will spend a majority of the time in the field interacting with external stakeholders, including investigators and clinical thought leaders, while also supporting internal stakeholders and continuing to maintain a high level of therapeutic expertise.

Requirements

• MD, PharmD, PhD, APP, PA, NP with experience in a specific Disease Area or with a broad medical background or relevant pharmaceutical experience
• Working in a scientific and/or clinical research environment.
• Field medical expertise preferred.
• Deep understanding of TL environment and needs.
• Strong oncology experience required
• Scientific or clinical disease area knowledge, patient treatment trends, clinical landscape
• Pharmaceutical industry including compliance and regulatory guidelines
• Understanding of scientific publications
• Clinical trial design and process
• Understanding of national and regional healthcare and access environment.
• Ability to analyze data, such as market trends, and HCP preferences.
• Ability to segment HCPs based on their preferences and other relevant factors.
• Ability to derive actionable insights from data and analytics, including CE^3 analytics engine.
• Providing feedback proactively to enable continuous improvement of technology and tools like CE^3.
• Ability to work independently and act as a team player by developing strong rapport and working relationships with external and internal stakeholders.
• Knowledge of the national healthcare and access environments.
• Deep knowledge and experience of RWE.
• Ability to interpret RWE and identify opportunities for RWE projects.
• Be a representative of BMS in all interactions with external stakeholders.
• Holds a high level of integrity and good judgment, to navigate the requirements of the role effectively and compliantly in accordance with BMS policies and procedures.

Nice To Haves

• Scientific Agility
• Ability to engage in a dialogue about data in a compelling, fair and balanced way and explain in a manner that resonates with TLs/HCPs
• Expert knowledge of clinical practice and evolving healthcare delivery models.
• Ability to understand and critically appraise scientific publications.
• Knowledge of clinical trial design and methodology, including Good Clinical Practices and ethical, governmental, and regulatory requirements.
• Understands treatment paradigms, competitive landscape and can frame information in a convincing and compliant way that resonates with physicians.
• Excellent communication and presentation skills to articulate scientific and clinical data in an easy-to-understand manner to help HCPs best serve their patients.
• Has a strong learning mindset and passion for science.
• Prioritizes staying current with the latest data.
• Patient centricity
• Understands the patient journey and experience.
• Has a patient-focused mindset.
• Customer-focused/enterprise mindset
• Understands overall enterprise objectives and prioritization.
• Winning Mindset: results-oriented, positive, resilient attitude, able to quickly adapt in an ever-changing environment.
• Willingness to embrace new ways of working and technological tools.
• Demonstrated ability to drive organizational performance.
• Experience identifying, engaging, and cultivating relationships with HCPs.
• Demonstrated ability to influence matrix organization and problem-solving mentality.
• Technological Agility
• Understanding, adapting, and effectively using technology in various aspects of healthcare business and interacting with HCPs.
• Utilizing various digital communication channels such as emails, instant messaging apps, and video conferencing to stay in touch with healthcare professionals, colleagues, and clients. This enables them to respond promptly to inquiries, share updates, and maintain effective communication.
• Competency using CE^3 and other software or CRM tools to collect, enter, and manage quality HCP data in a timely manner, track interactions, and plan future engagements with healthcare professionals.
• Ability to use the Medical on Call technology effectively.
• Being able to navigate and utilize the internet and online resources effectively.
• Keeping up to date with technological advancements and changes.
• Teamwork/Cross-functional mindset

Responsibilities

• Develops trusted relationships with appropriate academic and community Thought Leaders (TLs) in Oncology through high-quality peer-to-peer scientific dialogue in both proactive and reactive settings.
• The MSL will use various channels for interactions (1:1, group presentations, virtual, etc.) Medical engagement
• Effectively collaborates and engages in scientific dialogue with TLs to gain insights on clinical landscape to ensure development of a medical plan that is both product/disease area focused and translates into effective launch
• Proactively engages in scientific and clinical conversation to ensure development of a medical plan that is both product/disease area focused and translates into effective launch and LCM activities.
• Engages with medical societies, PAGs (Patient Advocacy Groups) and guideline committee members as appropriate.
• Provides training for external speakers as needed.
• Strategically engages payers in the pre- and peri-launch phases (with fHEOR and Account Executives).
• Provides medical support to address unsolicited HCP questions in real-time, both in face-to-face interactions and through the Medical on Call virtual capability.
• Develops credible connections with key Thought Leaders (TLs) in oncology through high-quality peer-to-peer scientific dialogue.
• Appropriately document and achieve annual goals
• Leverages digital capabilities to enhance medical engagement
• Provides recommendations and insights to clinical development team on study feasibilities within the therapeutic area based on knowledge of the field and through direct contacts with potential investigators, as agreed with home office medical and GDO.
• Liaises with key large accounts to understand clinical barriers to patient access and ensuring equity in access to clinical trials.
• Leads major evidence read-outs with clinical trial investigators e.g., Ph 3 top-line data.
• Support Interventional and Non-Interventional Research (NIR) studies (e.g. identification and assessment of potential study sites) to facilitate patient recruitment and/or discussions around the safe and effective use of BMS investigational products, as agreed with home office medical and Global Development Operations (GDO) and as defined by the study scope document
• Provide recommendations and insights to clinical development team on study and site feasibilities within the therapeutic area based on knowledge of the field and through direct contacts with potential investigators, as agreed with home office medical and GDO
• Support HCPs in the ISR submission and execution process and study follow-up as agreed upon with home office medical and GDO
• Ensure that BMS Pharmacovigilance procedural documents are understood and applied by investigators of local studies, and alert appropriate BMS personnel to any identified Adverse Events
• If applicable, support CRO sponsored studies as agreed with home office medical and GDO and as defined by the study scope document

Benefits

• Health Coverage: Medical, pharmacy, dental, and vision care.
• Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
• Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
• Work-life benefits include: Paid Time Off US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees)
• Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays
• Based on eligibility, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.
• All global employees full and part-time who are actively employed at and paid directly by BMS at the end of the calendar year are eligible to take advantage of the Global Shutdown.

What This Job Offers

• Job Type: Full-time
• Career Level: Senior